132 related articles for article (PubMed ID: 36646024)
1. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H
Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024
[TBL] [Abstract][Full Text] [Related]
2. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in breast cancer: A comprehensive analysis.
Zhu X; Song J; Wang M; Wang X; Lv L
J Gene Med; 2023 Mar; 25(3):e3471. PubMed ID: 36525372
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of long noncoding RNA and mRNA in five colorectal cancer tissues and five normal tissues.
Zhou ZX; Chen XM; Zhang YQ; Peng L; Xue XY; Li GX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32016349
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing.
Li M; Guo D; Chen X; Lu X; Huang X; Wu Y
BMC Cancer; 2022 Jul; 22(1):780. PubMed ID: 35842644
[TBL] [Abstract][Full Text] [Related]
9. Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types.
Wei Y; Zhou L; Huang Y; Guo D
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846981
[TBL] [Abstract][Full Text] [Related]
10. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
[TBL] [Abstract][Full Text] [Related]
11. Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer.
Liu H; Gu X; Wang G; Huang Y; Ju S; Huang J; Wang X
Aging (Albany NY); 2019 Aug; 11(16):6089-6108. PubMed ID: 31442207
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Shao J; Zhang Y; Fan G; Xin Y; Yao Y
BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
[TBL] [Abstract][Full Text] [Related]
13. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer.
Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A
BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803
[TBL] [Abstract][Full Text] [Related]
14. Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients.
Li M; Zhao LM; Li SL; Li J; Gao B; Wang FF; Wang SP; Hu XH; Cao J; Wang GY
Cancer Med; 2018 Sep; 7(9):4650-4664. PubMed ID: 30039525
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis.
Luo J; Xu L; Jiang Y; Zhuo D; Zhang S; Wu L; Xu H; Huang Y
Oncol Rep; 2016 Apr; 35(4):2035-44. PubMed ID: 26847923
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer.
Wu H; Wu R; Chen M; Li D; Dai J; Zhang Y; Gao K; Yu J; Hu G; Guo Y; Lin C; Li X
Oncotarget; 2017 Mar; 8(13):21095-21105. PubMed ID: 28177879
[TBL] [Abstract][Full Text] [Related]
17. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation.
Yang Z; Xu F; Wang H; Teschendorff AE; Xie F; He Y
EBioMedicine; 2021 Jun; 68():103399. PubMed ID: 34044218
[TBL] [Abstract][Full Text] [Related]
19. lncRNA-miRNA-mRNA interaction network for colorectal cancer; An in silico analysis.
Ghasemi T; Khalaj-Kondori M; Hosseinpour Feizi MA; Asadi P
Comput Biol Chem; 2020 Dec; 89():107370. PubMed ID: 32932199
[TBL] [Abstract][Full Text] [Related]
20. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
Front Immunol; 2022; 13():990143. PubMed ID: 36304471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
